RAC1 and pancreatic neoplasm: Rac1 and two of its GEFs, Tiam1 and Vav1, have been reported to be overexpressed in more than 70% of pancreatic cancers, and Vav1 overexpression has also been associated with poor prognosis in pancreatic cancer patients [46–49].